iBIO - Illinois Biotechnology Industry Organization
01/08/2025 | Press release | Distributed by Public on 01/08/2025 14:12
iBIO January Grants Report Highlights Expansive Funding Opportunities for Life Sciences Innovation
iBIO January Grants Report Highlights Expansive Funding Opportunities for Life Sciences Innovation
by John Conrad| Jan 8, 2025| Grants, NewsBrief
In partnership with G2G Consulting, we are please to provide the January 2025 Grants report, showcasing 196 non-dilutive government funding opportunities across diverse biomedical and life sciences sectors. The comprehensive report underscores significant funding potential in emerging fields like artificial intelligence, bioengineering, and precision medicine.
"Helping our members access non-dilutive funding is a core priority for iBIO," says John Conrad, President & CEO of iBIO. "Through our partnership with G2G Consulting, we're providing members with expert guidance and real-time intelligence on federal funding opportunities that can accelerate their innovations while preserving equity."
Notable opportunities include DARPA's HyBRIDS program exploring biohybrid platforms, ARPA-H's EHI Initiative supporting early career investigators, and multiple NIH grants focused on cancer research. The report highlights substantial funding in AI/ML applications for psychiatric drug development and FDA's PrecisionFDA GenAI Community Challenge.
Key focus areas receiving significant attention include:
- Cancer research (48 opportunities)
- Mental health initiatives (13 opportunities)
- Biomedical research (12 opportunities)
- AI & Machine Learning (10 opportunities)
Members can access detailed information through an upcoming webinar on January 16, 2025, featuring both open and premium sessions. Additionally, G2G will host a special webinar on January 22 focusing on the Military Health System Research Symposium, with abstract submissions due February 16.
The report also includes valuable recurring opportunities from major agencies including ARPA-H, BARDA, DARPA, and various military branches, offering diverse pathways for life sciences ventures to secure government funding while maintaining equity positions.